Early versus late enteral prophylactic iron supplementation in preterm very low birth weight infants: a randomised

Rojo Joy1, Sriram Krishnamurthy, Adhisivam Bethou

  • 1Departments of Pediatrics and Biochemistry, Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), , Pondicherry, India.

Insights

Early iron supplementation for preterm very low birth weight infants significantly boosts serum ferritin and hemoglobin levels by 12 weeks. This early intervention improves iron status without increasing neonatal morbidities.

Area of Science:

  • Neonatalogy
  • Pediatric Nutrition
  • Hematology

Background:

  • Iron deficiency is common in preterm very low birth weight (VLBW) infants.
  • Optimal timing for iron supplementation in VLBW infants is crucial for development.
  • Previous studies have shown varied outcomes regarding iron supplementation protocols.

Purpose of the Study:

  • To determine if early iron (EI) supplementation at 2 weeks postnatal age improves serum ferritin levels in preterm VLBW infants compared to late iron (LI) supplementation at 6 weeks.
  • To evaluate the impact of EI supplementation on hemoglobin levels and neonatal morbidities.

Main Methods:

  • A single-blinded, parallel-group, randomized controlled trial was conducted.
  • 104 preterm VLBW infants were randomized to receive either EI (2 mg/kg/day) or LI (2 mg/kg/day) starting at 2 or 6 weeks postnatal age, respectively.
  • Serum ferritin, hemoglobin, anthropometric parameters, and neonatal morbidities were assessed at 2, 6, and 12 weeks postnatal age.

Main Results:

  • Serum ferritin levels at 12 weeks were significantly higher in the EI group (82±5 ng/mL) compared to the LI group (63±3 ng/mL) (p<0.001).
  • Hemoglobin levels (10.1±0.4 vs 9.2±0.4 g/dL) and mean corpuscular hemoglobin concentration were also significantly higher in the EI group at 12 weeks (p<0.001).
  • No significant differences were observed in neonatal morbidities, anthropometric parameters, or blood transfusion requirements between the groups.

Conclusions:

  • Early iron supplementation (starting at 2 weeks) in preterm VLBW infants leads to improved serum ferritin and hemoglobin levels by 12 weeks.
  • EI supplementation is safe and effective in enhancing iron status in this vulnerable population.
  • The findings support the initiation of iron supplementation earlier in preterm VLBW infants.
Abstract

Related Concept Videos

Enteral Nutrition I: Orogastric and Nasogastric Feeding01:26

Enteral Nutrition I: Orogastric and Nasogastric Feeding

Enteral nutrition delivers nutrients directly to the stomach or small intestine through a tube. This method is appropriate for patients who cannot eat but still have a functioning digestive system. It is also beneficial for individuals with swallowing difficulties, anorexia, malabsorption, or those who have undergone gastrointestinal (GI) surgery.
Orogastric (OG) and nasogastric (NG) feeding are two standard methods used for enteral nutrition. Enteral nutrition is often preferred over...
3.1K
Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding01:15

Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding

Enteral nutrition encompasses various methods of delivering nutrition directly to the gastrointestinal (GI) tract, bypassing traditional oral intake. It is particularly beneficial for patients who cannot eat by mouth but have a functioning digestive system. Key methods include nasointestinal feeding, gastrostomy, and jejunostomy, each suited to different clinical scenarios based on the patient's needs and condition.
Nasointestinal Feeding
Nasointestinal feeding involves placing a tube...
2.0K
The Early Endosome: Endocytosis of Transferrin01:28

The Early Endosome: Endocytosis of Transferrin

Essential proteins such as insulin or low-density lipoprotein (LDL) and micronutrients such as iron enter a eukaryotic cell through receptor-mediated endocytosis. Subsequently, the early endosomes fuse with the vesicles containing such receptor-ligand complexes and play a vital role in sorting the incoming ligands and receptors. While the ligands are either degraded inside the vesicle or released into the cytosol, their receptors are returned to the plasma membrane for further rounds of...
4.1K
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
1.0K
Parentral Nutrition: Centeral and Peripheral Parental Nutrition01:27

Parentral Nutrition: Centeral and Peripheral Parental Nutrition

Parenteral Nutrition (PN) delivers essential nutrients directly into the bloodstream, bypassing the digestive system. It is commonly used for individuals with severe digestive disorders or conditions that prevent normal nutrient absorption.
PN can be administered through two primary routes:
1. Central Parenteral Nutrition (CPN):
CPN involves delivering a high concentration of nutrients through a large vein. This is typically achieved using a Peripherally Inserted Central Catheter (PICC) or,...
2.0K
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
967